Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

EMA suspends generic drugs on data integrity concerns

Reports by FDA and WHO find evidence of data manipulation by Semler Research Centre

- PMLiVE

Microsoft-backed doctors network expands in Europe

Among Doctors officially launches in the UK and Spain

- PMLiVE

HIV prevention pill heads July CHMP recommendations

Gilead’s Truvada given positive opinion alongside Ipsen Pharma’s Cabometyx and Eisai’s Kisplyx

- PMLiVE

Wilmington Healthcare appoints managing director

Gareth Thomas joins the healthcare intelligence provider

- PMLiVE

GSK launches first pharma trial powered by Apple’s ResearchKit

Will use an iPhone app built using the software for a real-world study

EU flag

EU proposes reforms to make first-in-human trials safer

New guideline revision paper “takes into account lessons learnt” from fatal Bial trial

Biogen Idec building

Biogen’s CEO Scangos to step down

Departure comes as multiple sclerosis drug Tecfidera achieves improved sales growth

- PMLiVE

Astellas promotes John Demaree

He becomes vice president of oncology marketing, Americas

- PMLiVE

Gilead’s universal hep C therapy Epclusa approved in EU

European nod for first pan-genotypic treatment follows recent FDA licensing

- PMLiVE

Ireland ekes out major savings in drug pricing deal

Four-year pharma agreement will save an estimated €600m

Roche Basel Switzerland

Roche says Tecentriq “off to a good start”

Bladder cancer therapy drug seems set for rapid growth

National Institute for Health and Care Excellence NICE logo

NICE backs PTC’s muscular dystrophy drug Translarna

Drug to be available on the NHS for DMD patients aged five and over

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links